Jon E. Angell

Array ( [id] => 8005597 [patent_doc_number] => 08084199 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-27 [patent_title] => 'Method of diagnosing poor survival prognosis colon cancer using microRNA-21' [patent_app_type] => utility [patent_app_number] => 12/373358 [patent_app_country] => US [patent_app_date] => 2007-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 40554 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/084/08084199.pdf [firstpage_image] =>[orig_patent_app_number] => 12373358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5534197 [patent_doc_number] => 20090233985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING HIV INFECTIONS BY INHIBITING LEREPO4 AND GLIPR' [patent_app_type] => utility [patent_app_number] => 12/373282 [patent_app_country] => US [patent_app_date] => 2007-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 31216 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233985.pdf [firstpage_image] =>[orig_patent_app_number] => 12373282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4921525 [patent_doc_number] => 20080069840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'RNA Interference That Blocks Expression of Pro-Apoptotic Proteins Potentiates Immunity Induced by DNA and Transfected Dendritic Cell Vaccines' [patent_app_type] => utility [patent_app_number] => 11/773162 [patent_app_country] => US [patent_app_date] => 2007-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 46874 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20080069840.pdf [firstpage_image] =>[orig_patent_app_number] => 11773162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4651527 [patent_doc_number] => 20080038783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Compositions and Methods Pertaining to Guanylation of PNA Oligomers' [patent_app_type] => utility [patent_app_number] => 11/769869 [patent_app_country] => US [patent_app_date] => 2007-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10196 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20080038783.pdf [firstpage_image] =>[orig_patent_app_number] => 11769869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4572333 [patent_doc_number] => 07824850 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => 'Methods of protein destabilization and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/821562 [patent_app_country] => US [patent_app_date] => 2007-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 32163 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/824/07824850.pdf [firstpage_image] =>[orig_patent_app_number] => 11821562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10169573 [patent_doc_number] => 09200275 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-01 [patent_title] => 'Methods and compositions for regulating cell cycle progression' [patent_app_type] => utility [patent_app_number] => 12/304968 [patent_app_country] => US [patent_app_date] => 2007-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 24 [patent_no_of_words] => 33992 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12304968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016842 [patent_doc_number] => 20070260051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'siRNA targeting pituitary tumor-transforming 1 (PTTG1)' [patent_app_type] => utility [patent_app_number] => 11/811925 [patent_app_country] => US [patent_app_date] => 2007-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 12457 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20070260051.pdf [firstpage_image] =>[orig_patent_app_number] => 11811925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10032894 [patent_doc_number] => 09074202 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Method of inhibiting human Trabid' [patent_app_type] => utility [patent_app_number] => 12/302317 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 20146 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12302317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4965764 [patent_doc_number] => 20080108584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF IKK-B GENE' [patent_app_type] => utility [patent_app_number] => 11/751283 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 27356 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108584.pdf [firstpage_image] =>[orig_patent_app_number] => 11751283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6537230 [patent_doc_number] => 20100015707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'SHORT INTERFERING RIBONUCLEIC ACID (siRNA) FOR ORAL ADMINISTRATION' [patent_app_type] => utility [patent_app_number] => 12/299396 [patent_app_country] => US [patent_app_date] => 2007-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11461 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015707.pdf [firstpage_image] =>[orig_patent_app_number] => 12299396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10045389 [patent_doc_number] => 09085778 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-21 [patent_title] => 'Exosome transfer of nucleic acids to cells' [patent_app_type] => utility [patent_app_number] => 11/799148 [patent_app_country] => US [patent_app_date] => 2007-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4970 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11799148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886389 [patent_doc_number] => 20080260721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Nucleic acids encoding a mammalian raptor polypeptide and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/788024 [patent_app_country] => US [patent_app_date] => 2007-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 23948 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260721.pdf [firstpage_image] =>[orig_patent_app_number] => 11788024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5126597 [patent_doc_number] => 20070238868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'siRNA targeting chemokine (C-X-C motif) receptor 4 (CXCR4)' [patent_app_type] => utility [patent_app_number] => 11/732413 [patent_app_country] => US [patent_app_date] => 2007-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 34213 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238868.pdf [firstpage_image] =>[orig_patent_app_number] => 11732413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146711 [patent_doc_number] => 08163708 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Pharmaceutical composition comprising anti-mirna antisense oligonucleotide' [patent_app_type] => utility [patent_app_number] => 12/295960 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 33 [patent_no_of_words] => 39558 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163708.pdf [firstpage_image] =>[orig_patent_app_number] => 12295960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4693090 [patent_doc_number] => 20080085861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'GAS1 POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 11/691714 [patent_app_country] => US [patent_app_date] => 2007-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9931 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085861.pdf [firstpage_image] =>[orig_patent_app_number] => 11691714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8576852 [patent_doc_number] => 08343061 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-01 [patent_title] => 'Method and apparatus for determining central aortic pressure waveform' [patent_app_type] => utility [patent_app_number] => 12/225141 [patent_app_country] => US [patent_app_date] => 2007-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4637 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12225141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539870 [patent_doc_number] => 20090221675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'USE OF IEX-1 FOR THE TREATMENT OF GLIOMA TUMORS' [patent_app_type] => utility [patent_app_number] => 12/162097 [patent_app_country] => US [patent_app_date] => 2007-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6219 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221675.pdf [firstpage_image] =>[orig_patent_app_number] => 12162097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6485212 [patent_doc_number] => 20100092969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'CELL ISOLATION METHOD, CELL TESTING METHOD AND REAGENT KIT THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/530154 [patent_app_country] => US [patent_app_date] => 2007-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6458 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092969.pdf [firstpage_image] =>[orig_patent_app_number] => 12530154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458272 [patent_doc_number] => 20090258424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Cellular Delivery of siRNA' [patent_app_type] => utility [patent_app_number] => 12/280468 [patent_app_country] => US [patent_app_date] => 2007-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16841 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258424.pdf [firstpage_image] =>[orig_patent_app_number] => 12280468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5023509 [patent_doc_number] => 20070149475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'AUGMENTATION OF WOUND HEALING BY eIF-4E mRNA AND EGF mRNA' [patent_app_type] => utility [patent_app_number] => 11/680243 [patent_app_country] => US [patent_app_date] => 2007-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9583 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20070149475.pdf [firstpage_image] =>[orig_patent_app_number] => 11680243 [rel_patent_id] =>[rel_patent_doc_number] =>)